Evidence map›Paper›PMID 42588565›Full record

ArticleMolecules (Basel, Switzerland)2026

Lipidomics Based on HILIC-ESI-HRMS Reveal Subtle Changes in the Mitochondrial Phospholipidome of Mouse Embryonic Fibroblasts Expressing Pathogenic Variants of Human OPA1 Protein.

Andrea Castellaneta, Ilario Losito, Vito Porcelli, Serena Barile, Alessandra Maresca, Valentina Del Dotto, Penelope Magnoni, Claudia Zanna, Ludovica Sofia Guadalupi, Valeria Cinquepalmi and 5 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Andrea CastellanetaDipartimento di Chimica, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70126 Bari, Italy.ORCID 0000-0001-5249-7168
Ilario LositoDipartimento di Chimica, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70126 Bari, Italy.ORCID 0000-0003-0025-3350
Vito PorcelliDipartimento di Bioscienze, Biotecnologie e Ambiente, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70126 Bari, Italy.ORCID 0000-0002-3634-9613
Serena BarileDipartimento di Bioscienze, Biotecnologie e Ambiente, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70126 Bari, Italy.
Alessandra MarescaProgramma di Neurogenetica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura 3, 40139 Bologna, Italy.ORCID 0000-0002-8959-8832
Valentina Del DottoDipartimento di Scienze Biomediche e Neuromotorie, Università degli Studi di Bologna, Via Altura 3, 40139 Bologna, Italy.ORCID 0000-0002-6053-0893
Penelope MagnoniProgramma di Neurogenetica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura 3, 40139 Bologna, Italy.
Claudia ZannaDipartimento di Scienze Biomediche e Neuromotorie, Università degli Studi di Bologna, Via Altura 3, 40139 Bologna, Italy.ORCID 0000-0002-0647-5360
Ludovica Sofia GuadalupiDipartimento di Chimica, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70126 Bari, Italy.ORCID 0009-0001-1168-5733
Valeria CinquepalmiDipartimento di Chimica, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70126 Bari, Italy.ORCID 0009-0002-0733-4452
Cosima Damiana CalvanoDipartimento di Chimica, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70126 Bari, Italy.ORCID 0000-0001-8832-7072
David C ChanDivision of Biology and Biological Engineering, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA.
Valerio CarelliProgramma di Neurogenetica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura 3, 40139 Bologna, Italy.ORCID 0000-0003-4923-6404
Luigi PalmieriDipartimento di Bioscienze, Biotecnologie e Ambiente, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70126 Bari, Italy.ORCID 0000-0002-6503-2922
Tommaso R I CataldiDipartimento di Chimica, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70126 Bari, Italy.ORCID 0000-0003-4811-8959

Funding

Ministry of Universities and Research 20172T2MHH_002
6 · The paper itself

Abstract

Pathogenic variants of the mammalian optic atrophy 1 (OPA1) protein, a key regulator of mitochondrial fusion, may lead to severe mitochondrial dysfunction and morphological alterations, and have also been proposed to be involved in remodeling the mitochondrial membranes lipid profile. To address this last issue, a lipidomic workflow based on HILIC-ESI-HRMS was applied to profile major classes of mitochondrial membrane phospholipids (PL), namely phosphatidylcholines (PCs), -ethanolamines (PEs), and -inositols (PIs), along with cardiolipins (CLs), in mouse embryonic fibroblasts knocked out for Opa1 gene (Opa1

Indexed as

FibroblastsGTP PhosphohydrolasesLipidomicsMitochondriaPhospholipidsAnimalsEmbryo, MammalianHumansLiquid Chromatography-Mass SpectrometryMiceMitochondrial MembranesSpectrometry, Mass, Electrospray IonizationGTP PhosphohydrolasesOPA1 protein, humanOpa1 protein, mousePhospholipidsHILIC-ESI-HRMShuman OPA1lipidomicsmitochondriamouse embryonic fibroblastsOPA1 variants

Identifiers

PMID42588565
PMCPMC13468052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.